Database of all sotrovimab COVID-19 studies. Submit updates/corrections .
May 26 |
Early | (Preprint) | death, ↓66.6%, p=1.00 | Sotrovimab Clinical, Safety, & Variant Information |
| Details Interim results from the COMET-ICE trial showing lower mortality and progression with treatment. NCT04545060. | ||||
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All
practical, effective, and safe means should be used. Elimination of COVID-19
is a race against viral evolution. No treatment, vaccine, or intervention is
100% available and effective for all current and future variants. Denying the
efficacy of any method increases the risk of COVID-19 becoming endemic; and
increases mortality, morbidity, and collateral damage. We do not provide
medical advice. Before taking any medication, consult a qualified physician
who can provide personalized advice and details of risks and benefits based
on your medical history and situation. Treatment protocols for physicians are
available from the FLCCC.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.